pcDNA™3.2/GW/D-TOPO™ Expression Kit
Product Image
Invitrogen™

pcDNA™3.2/GW/D-TOPO™ Expression Kit

Los vectores pcDNA™ están diseñados para una expresión constitutiva de alto nivel en diversas líneas celulares de mamíferos. El vectorMás información
Have Questions?
Número de catálogoCantidad
K24402020 reacciones
Número de catálogo K244020
Precio (CLP)
1.407.557
Each
Añadir al carro de la compra
Cantidad:
20 reacciones
Precio (CLP)
1.407.557
Each
Añadir al carro de la compra
Los vectores pcDNA™ están diseñados para una expresión constitutiva de alto nivel en diversas líneas celulares de mamíferos. El vector pcDNA3.2/GW/D-TOPO ofrece las siguientes características clave:

•Promotor de citomegalovirus (CMV) para expresión de alto nivel
•Adaptado para TOPO™ direccional clonación, permite el uso de polimerasas de corrección y la clonación de productos PCR en una orientación específica
•Gen de resistencia a la neomicina para una selección estable
•Etiqueta C-terminal V5 para una detección sencilla
•Gen de resistencia a la ampicilina y origen de pUC para la selección y el mantenimiento en E. coli

TOPO™ La clonación
con enzimas de restricción para clonar el gen en un vector de expresión fuerza a comprometerse en la secuencia final de la inserción (Figura 1A), sobre todo cuando no existen sitios de restricción útiles cercanos a la secuencia de codificación genética. Esto puede dar lugar a un espaciado subóptimo de los elementos de expresión o a la incorporación de residuos de aminoácidos no nativos, lo que a su vez reduce los niveles de expresión o causa la producción de proteínas no funcionales.

Además de ser una forma más eficaz de clonar, la clonación TOPO™ elimina estos posibles problemas de expresión. Los vectores de expresión TOPO™ permiten insertar la secuencia de ADN el exacta necesaria simplemente con realizar una PCR con primers diseñados adecuadamente. El producto de PCR se clona con alta eficacia en solo cinco minutos en un vector de expresión activado por la topoisomerasa I. El vector de expresión recombinante resultante contiene una secuencia exacta de ADN sin regiones no codificantes (Figura 1B).

Muchos de nuestros potentes vectores de expresión están disponibles adaptados para la clonación TOPO™ en un solo paso y la expresión de productos PCR. Además, actualmente hay varios vectores de expresión adaptados para la clonación TOPO™ direccional, lo que permite utilizar polimerasas de corrección y clonar los productos de PCR en una orientación específica.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Sistema constitutivo o inducibleConstitutivo
Tipo de entregaTransfección
Para utilizar con (aplicación)Expresión constitutiva
Tipo de productoKit de expresión TOPO
Cantidad20 reacciones
Agente de selección (eucariótico)Geneticin™ (G-418)
VectorpcDNA
Método de clonaciónTOPO, Gateway, TOPO direccional
Línea de productosGateway, TOPO, pcDNA
PromotorCMV
Etiqueta de proteínaEtiqueta de epítopo V5
Unit SizeEach
Contenido y almacenamiento
Almacenar en congelador ultrafrío (entre -68 y -85 °C).

Preguntas frecuentes

Your Gateway-adapted TOPO vectors are supplied with a control template and control primers. Can I obtain the sequence of the control template?

The sequence of the control template is proprietary.

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.